Eir Accelerator Selects 15 Women’s Health Startups for Inaugural Cohort
Eir Accelerator, a Finland-based programme for women's health companies, has picked 15 startups for its first cohort. The companies span diagnostics, therapeutics, medical devices and digital health.
The named companies include Yuthera, a wearable for period and pelvic pain; Medara, an AI model for breast cancer risk; and Metri Bio, which develops therapeutics for endometriosis and uterine disease. Also in the group are NEXT Life Sciences, a reproductive health platform company developing an endometriosis treatment; Metluma, a women's telehealth platform; and Huna, an AI-assisted risk test for common cancers. Misala Med works on AI-assisted diagnostics and therapeutics, and EloCare makes a cooling wearable for menopause. Periwinkle Technologies has an AI point-of-care system for cervical cancer screening, and WomenX Biotech is building a pad-based diagnostics platform. ATB Antivirals is developing a topical therapy for HPV, DecipHER Women a peripartum depression prediction algorithm, and MagCath a urinary incontinence device. Optimovo is an infertility biotech company, and Thestra offers an AI-assisted biomarker test for tumor assessment. The source's list is abridged in places, so this is not a complete roster of all 15.
Anastasiya Markvarde, Head of Eir Accelerator, said the companies chose Finland because they can work with its biobanks, hospitals and research institutions. She added that they can also build relationships with investors and pharmaceutical partners who understand women's health.
Several of the startups use AI, notably in cancer risk assessment, screening, diagnostics and depression prediction. The cohort reflects a Nordic push to build a women's health ecosystem around Finland's research infrastructure and health data resources.